HuGE Literature Finder
Records 1-15
|
Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study.
Asian Pacific journal of cancer prevention : APJCP 2020 Aug 21 (8): 2381-2388. Lertkhachonsuk Arb-Aroon, Suprasert Prapaporn, Manchana Tarinee, Kittisiam Thannaporn, Kantathavorn Nuttavut, Chansoon Tharintorn, Khunamornpong Surapan, Pohthipornthawat Natkrita, Tangjitgamol Siriwan, Luasiripanthu Taksa, Teerapakpinyo Chinachote, Shuangshot Shanop, Iemwimangsa Nareenart, Chantratita Was |
|
The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.
Radiology and oncology 2020 May 54 (2): 180-186. Gornjec Andreja, Merlo Sebastijan, Novakovic Srdjan, Stegel Vida, Gazic Barbara, Perhavec Andraz, Blatnik Ana, Krajc Mate |
|
Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.
International journal of clinical oncology 2019 May . Nomura Hidetaka, Sekine Masayuki, Yokoyama Shiro, Arai Masami, Enomoto Takayuki, Takeshima Nobuhiro, Nakamura Sei |
|
Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.
Journal of human genetics 2018 Apr 63 (4): 447-457. Arai Masami, Yokoyama Shiro, Watanabe Chie, Yoshida Reiko, Kita Mizuho, Okawa Megumi, Sakurai Akihiro, Sekine Masayuki, Yotsumoto Junko, Nomura Hiroyuki, Akama Yoshinori, Inuzuka Mayuko, Nomizu Tadashi, Enomoto Takayuki, Nakamura Sei |
|
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An NRG Oncology/Gynecologic Oncology Group study.
Gynecologic oncology 2015 Jun 137 (3): 386-91. Coleman Robert L, Sill Michael W, Bell-McGuinn Katherine, Aghajanian Carol, Gray Heidi J, Tewari Krishnansu S, Rubin Steven C, Rutherford Thomas J, Chan John K, Chen Alice, Swisher Elizabeth |
|
Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.
Familial cancer 2014 Jun 13 (2): 197-203. Chen Ying, Bancroft Elizabeth, Ashley Sue, Arden-Jones Audrey, Thomas Sarah, Shanley Susan, Saya Sibel, , Wakeling Emma, Eeles Rosali |
|
Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 May 32 (15): 1547-53. Finch Amy P M, Lubinski Jan, Møller Pål, Singer Christian F, Karlan Beth, Senter Leigha, Rosen Barry, Maehle Lovise, Ghadirian Parviz, Cybulski Cezary, Huzarski Tomasz, Eisen Andrea, Foulkes William D, Kim-Sing Charmaine, Ainsworth Peter, Tung Nadine, Lynch Henry T, Neuhausen Susan, Metcalfe Kelly A, Thompson Islay, Murphy Joan, Sun Ping, Narod Steven |
|
Clinical implications of genetic testing for BRCA1 and BRCA2 mutations in Austria.
Clinical genetics 2014 Jan 85 (1): 72-5. Singer C F, Muhr D, Rappaport C, Tea M-K, Gschwantler-Kaulich D, Fink-Retter A, Pfeiler G, Berger A, Sun P, Narod S |
|
Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
European journal of cancer (Oxford, England : 1990) 2013 Jan 49 (1): 132-41. Reitsma Welmoed, de Bock Geertruida H, Oosterwijk Jan C, Bart Joost, Hollema Harry, Mourits Marian J |
|
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
Cancer 2012 Aug 118 (15): 3703-9. Hyman David M, Zhou Qin, Iasonos Alexia, Grisham Rachel N, Arnold Angela G, Phillips Mary F, Bhatia Jasmine, Levine Douglas A, Aghajanian Carol, Offit Kenneth, Barakat Richard R, Spriggs David R, Kauff Noah |
|
Clinicopathologic characteristics and survival in BRCA1- and BRCA2-related adnexal cancer: are they different?
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012 May 22 (4): 579-85. Reitsma Welmoed, de Bock Geertruida H, Oosterwijk Jan C, ten Hoor Klaske A, Hollema Harry, Mourits Marian J |
|
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.
Journal of the National Cancer Institute 2003 Jul 95 (14): 1072-8. Rutter Joni L, Wacholder Sholom, Chetrit Angela, Lubin Flora, Menczer Joseph, Ebbers Sarah, Tucker Margaret A, Struewing Jeffery P, Hartge Patric |
|
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israel.
Gynecologic oncology 2003 Jun 89 (3): 494-8. Hirsh-Yechezkel G, Chetrit A, Lubin F, Friedman E, Peretz T, Gershoni R, Rizel S, Struewing J P, Modan |
|
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
The New England journal of medicine 2002 May 346 (21): 1609-15. Kauff Noah D, Satagopan Jaya M, Robson Mark E, Scheuer Lauren, Hensley Martee, Hudis Clifford A, Ellis Nathan A, Boyd Jeff, Borgen Patrick I, Barakat Richard R, Norton Larry, Castiel Mercedes, Nafa Khedoudja, Offit Kenne |
|
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Mar 20 (5): 1260-8. Scheuer Lauren, Kauff Noah, Robson Mark, Kelly Bridget, Barakat Richard, Satagopan Jaya, Ellis Nathan, Hensley Martee, Boyd Jeff, Borgen Patrick, Norton Larry, Offit Kenne |
- Page last reviewed:Oct 1, 2020
- Page last updated:Oct 28, 2020
- Content source: